Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

Item

http://www.wikidata.org/entity/Q42252396

Q42252396

about

Efflux-mediated drug resistance in bacteria: an update Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.Telithromycin in lower respiratory tract infections.Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae.Telithromycin-resistant Streptococcus pneumoniae.Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.

P2860

Q24609407-CBE52455-6383-4E24-93B6-A936C2E45207 Q36320613-B7B8F107-E377-4D88-B374-AD13743E15EC Q36895727-3360C3E5-982E-4C03-A0F5-F5D574279B05 Q37116814-31FAE698-3B08-4EAC-B0D0-1E8044D1D90B Q37927017-EFEC3ECA-3A85-40DE-9A86-1E41FACA48FA Q42111255-5B5BF894-529B-4D18-8D12-32A19E85CD1F Q42572351-C225EA95-2F91-4281-A619-8C01E1B63CAD Q51100124-3EC0CA33-17E0-47D7-848A-B5D55A0DC384

P2860

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

Item

http://www.wikidata.org/entity/Q42252396

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Pharmacodynamic activity of te ...... which telithromycin MICs vary

@en

Pharmacodynamic activity of te ...... al lining fluid against efflux

@nl

type

Item

label

Pharmacodynamic activity of te ...... which telithromycin MICs vary

@en

Pharmacodynamic activity of te ...... al lining fluid against efflux

@nl

prefLabel

Pharmacodynamic activity of te ...... which telithromycin MICs vary

@en

Pharmacodynamic activity of te ...... al lining fluid against efflux

@nl

P1476

Pharmacodynamic activity of te ...... which telithromycin MICs vary

@en

P2093

Aleksandra Wierzbowski

http://www.w3.org/2001/XMLSchema#string

Christel Johanson

http://www.w3.org/2001/XMLSchema#string

Daryl J Hoban

http://www.w3.org/2001/XMLSchema#string

Nancy Laing

http://www.w3.org/2001/XMLSchema#string

Tamiko Hisanaga

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin.

Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).

Pharmacodynamics of telithromycin In vitro against respiratory tract pathogens.

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides

Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.

Review of macrolides and ketolides: focus on respiratory tract infections.

Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae

P304

1943-1948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.5.1943-1948.2005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

George G Zhanel

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7881590

http://www.w3.org/2001/XMLSchema#string

P698

15855517

http://www.w3.org/2001/XMLSchema#string

P932

1087669

http://www.w3.org/2001/XMLSchema#string

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

about

P2860

P2860

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932